Naproxeno Sódico Cinfa (Naproxen Sodium)

Naproxen sodium, the active ingredient in Naproxeno Sódico Cinfa, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for mild to moderate pain and inflammatory conditions. GNH USA supplies Naproxeno Sódico Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxeno Sódico Cinfa, an NSAID, is employed in several painful and inflammatory disease states. - Mild to moderate pain: delivers analgesic relief for acute or chronic pain episodes. - Osteoarthritis: reduces joint inflammation and improves functional mobility. - Rheumatoid arthritis: helps control systemic inflammation and joint damage progression. - Musculoskeletal pain: alleviates strain‑related discomfort in muscles and tendons. - Dysmenorrhea: eases menstrual cramp pain and associated uterine inflammation.

Adverse reactions may occur with naproxen sodium use.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash: transient erythema or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding, which can be life‑threatening. - Cardiovascular events such as myocardial infarction or stroke, especially with long‑term use. - Acute renal impairment or worsening of chronic kidney disease. - Severe cutaneous reactions, including Stevens‑Johnson syndrome. - Hepatic injury presenting as jaundice or elevated liver enzymes. - Anaphylaxis: rapid onset of airway swelling, hypotension or urticaria.

Before initiating therapy, consider the following safety measures. - Cardiovascular risk assessment: evaluate history of heart disease or stroke. - Gastrointestinal history: avoid in patients with active ulcer disease or recent GI bleeding. - Renal function monitoring: check serum creatinine in those with renal impairment. - Concomitant anticoagulant use: monitor coagulation parameters closely. - Hypersensitivity screening: discontinue if allergic reactions develop. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Naproxen sodium can alter the activity of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in antihypertensive effect and renal perfusion. - Methotrexate: naproxen may raise methotrexate plasma levels, risking toxicity. - Corticosteroids: combined use can exacerbate ulcer formation and GI bleeding.